US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 18:43:06 Source：World Wander news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Mohammad Mokhber: Who is Iran’s acting president?
- Next：Company wins court ruling to continue development of Michigan factory serving EV industry
Related articles
- College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at
- Boeing CEO Dave Calhoun to step down in shakeup amid safety crisis
- TikTok is facing a ban in the United States. What would that mean for New Zealand?
- Auckland lodge fire: Caravan user forced to stick to one set of clothes
- 'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
- Israel approves plan to attack Rafah but keeps truce hopes alive
- Woman's death after electric blanket fire triggers warning from Coroner
- UN mission probing Islamic State crimes forced to shut in Iraq
- Celebrity birthdays for the week of May 26
- Report recommends councillors don't support plan for second Auckland harbour crossing
- OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
- Human Rights Commission advises caution over boot camps
- 'They cruise, we lose'
- Opportunities Party leader Raf Manji resigns
- Verona confirms Serie A status for another year after beating Salernitana
- Coronavirus death toll in Italy surpasses China
- Far North councillors vote 9 to 1 to seek delay in adding fluoride to water supply
- Majority of young New Zealanders want to 'live in a smoke free nation'
- Russian theater director and playwright go on trial over a play authorities say justifies terrorism
- Future of Picton overbridge up in the air
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,World Wander news portal sitemap